SOFT TISSUE SARCOMA RETROSPECTIVE ANALYSIS

Soft Tissue Sarcomas (STS) represent a group of rare tumors, histopathologically diverse group of neoplasm arising from mesenchymal cells including adipose, muscle, and connective tissues. The standard treatment of sarcomas in the localized stage is local excision and radiotherapy. Radiotherapy may be delivered either preoperatively, by brachytherapy after intra-operative placement of needles and post-operatively. Results - From August 2012 and December 2013, 85 patients with primary soft tissue sarcoma were seen in Radiotherapy Unit 1. Majority of our patients were above the age of 30 years. The incidence among males was 70. STS predominantly was found in lower extremities (51.1 in lower limb, 16.4 in upper limb). Among the patients treated with surgery most of them had wide local excision. Adjuvant radiotherapy was received by 61 patients. Palliative radiotherapy was received by 2 patients for brain and vertebral metastasis. The follow up period ranged from 6- 24 months. Out of 64 patients, no evidence of disease was seen in 34 patients, local recurrence in 1 patient who was treated with surgery alone and distant metastases in 9 patients. Twenty patients were lost to follow up.